Literature DB >> 6187865

A monoclonal antibody with specificity for murine mu heavy chain which inhibits the formation of antigen-specific direct IgM plaques.

M Leptin, F Melchers.   

Abstract

A panel of monoclonal rat antibodies binding to mouse mu heavy chain were tested for their ability to inhibit the formation of antigen-specific plaques in the hemolytic plaque assay. Nine antibodies inhibited SRC-specific direct IgM plaques at high concentrations (greater than 20 micrograms/ml). In contrast to all others, however, one antibody inhibited these plaques at much lower concentrations (down to 0.4 microgram/ml) when added to the assay. This antibody also inhibited plaques formed by cells secreting antibodies against trinitrophenyl or phosphorylcholine determinants. IgG plaques with any of the above specificities were not inhibited. IgM secretion was unaffected by the monoclonal anti-mu antibody. Its inhibitory effect on plaque formation rather appears to be a consequence of its ability to inhibit complement dependent, IgM mediated lysis of erythrocytes. This monoclonal anti-IgM antibody therefore provides a convenient reagent to distinguish specific direct IgM plaques from indirect IgG plaques.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6187865     DOI: 10.1016/0022-1759(83)90145-x

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Activation of complement by immunoglobulin M is impaired by the substitution serine-406----asparagine in the immunoglobulin mu heavy chain.

Authors:  M J Shulman; N Pennell; C Collins; N Hozumi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

2.  Differential STIM1 expression in T and B cell subsets suggests a role in determining antigen receptor signal amplitude.

Authors:  Yuval Yarkoni; John C Cambier
Journal:  Mol Immunol       Date:  2011-06-12       Impact factor: 4.407

3.  B cell tolerance in mice transgenic for anti-CD8 immunoglobulin mu chain.

Authors:  F Brombacher; G Köhler; H Eibel
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

4.  Elimination of CD8+ thymocytes in transgenic mice expressing an anti-Lyt2.2 immunoglobulin heavy chain gene.

Authors:  F Brombacher; M C Lamers; G Köhler; H Eibel
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.